Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis

Cong Wang,Xianxin Xie,Weijie Li,Daqing Jiang
DOI: https://doi.org/10.1002/jcla.24647
IF: 3.124
2022-08-12
Journal of Clinical Laboratory Analysis
Abstract:Totally 195 breast cancer patients underwent surgical resection were analyzed. KIF2A, NDC80, CDK1, and CCNB1 expressions were determined by immunohistochemistry. KIF2A expression positively associated with NDC80, CDK1, and CCNB1 expressions (all p 0.05). Background Kinesin family member 2A (KIF2A), nuclear division cycle 80 (NDC80), cyclin‐dependent kinase 1 (CDK1), and cyclin B1 (CCNB1) exhibit a complex interrelation, which promote cancer progression via multiple ways, whereas their interaction and clinical implications in breast cancer are obscure. Hence, this study aimed to evaluate the correlation among KIF2A, NDC80, CDK1, CCNB1, and their linkage with clinicopathological features and prognosis in breast cancer patients. Methods 195 breast cancer patients underwent surgical resection were analyzed. KIF2A, NDC80, CDK1, and CCNB1 expressions were determined by immunohistochemical (IHC) assay and scored by a semiquantitative IHC score or positive cell percentage. Results KIF2A expression positively associated with NDC80, CDK1, and CCNB1 expressions (all p
medical laboratory technology
What problem does this paper attempt to address?